ee-tp
Recombinant proteinexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2019 (NCT03866954)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Thymidine phosphorylaseSupplementation
TYMP supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03866954 | Phase 2 | Mar 31, 2019 | Neopharm, The Clinical Trial Company, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neopharm | For profit | 1 | 0 | 1 | 2019 |
| The Clinical Trial Company | For profit | 1 | 0 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1